Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Liver Cancer (Primary and Metastatic)
Interventions
DEVICE

NexGel

When a planned perfused area includes two or more Couinaud segments and more than 50% of the target area is non-tumorous liver, short-acting gelatin sponge particles (NexGel) will be administered to the hepatic arteries toward the non-tumorous liver. The embolization particles will be prepared by mixing one vial of the particles with 5 mL of iodinated contrast agents and intra-arterially delivered with a microcatheter 2.0-Fr or larger. After confirming the disappearance or substantial reduction of liver parenchymal staining of the embolized area on angiography, radioembolization using Y90 glass or resin microspheres will be conducted. Digital subtraction angiography will be performed 30 minutes after the transient embolization to identify recanalization of the transiently embolized hepatic arteries.

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Next Biomedical Co., Ltd.

INDUSTRY

NCT06229080 - Short-term Embolization Using Gelatin Particles for FloW ModulAtion During Y90 Radioembolization | Biotech Hunter | Biotech Hunter